CCT-102 or Expectant Management in Delayed Pregnancy Loss

Inclusion Criteria: 1. Age 18 to 50 2. Ability to provide informed consent 3. Hemodynamically stable 4. Closed cervical os 5. If fetus exists, clinical observation indicates gestation is no more than 10 weeks 6. Diagnosis of delayed pregnancy loss, confirmed by ultrasound, based on: 1. Embryonic demise: no embryonic cardiac activity when embryo measures 7 mm or greater; OR, 2. Anembryonic pregnancy: mean gestational sac diameter of 25 mm or greater, with no detectable embryo. Exclusion Criteria: 1. Unwillingness or inability to comply with the study protocol and visit schedule 2. Diagnosis of an incomplete or inevitable abortion including more than slight bleeding at enrollment and/or open os within the prior week. 3. Confirmed or suspected ectopic pregnancy or undiagnosed adnexal mass 4. Hemoglobin \<10 g/dL 5. Coagulation disorder, inherited porphyrias, and/or current anticoagulants use 6. Chronic adrenal failure 7. Concurrent chronic corticosteroid therapy 8. History of trophoblastic disease 9. Current presence of an IUD 10. History of allergy or contraindications to the use to mifepristone, misoprostol, or other prostaglandins 11. Any condition that, in the opinion of the investigator, makes the patient unsuitable for study entry 12. Any other current medical condition that jeopardizes the patient's ability to safely participate in the trial